Clinical Approach of Clostridium Difficile-Associated Diarrhea (CDAD) Treatment by Oral Vancomycin of Isolated Stool Samples of Contaminated Drinking Water in Basrah, Iraq
Received Date: Apr 24, 2020 / Accepted Date: Jun 11, 2020 / Published Date: Jun 18, 2020
Abstract
The aim of this study to trend the clinical treatment of clostridium difficile infected patient by oral vancomycin with lowering of patient risk through control of antibiotic's prescription in hospitals. Clostridium difficile is common cause in inflammation of colon, symptoms of abdominal pain/tenderness diarrhea, fever and colitis. If not carefully managed, it will be possible prognosis to life-threatening cases of mega colon and multi-organ failure. Clinical approach in treatment of C. difficile infection (CDI), was by using (FIRVANQ™) contains vancomycin reconstituted oral glucopeptide preparation of 15g vancomycin, which is given to 20 cases of teenage, were admitted in polyclinic in summer (2019), Basrah governate, IRAQ to treat C. difficile-associated diarrhea outbreak depending on therapeutic oral vancomycin as multiple dose of 40 mg/kg for several days.
Keywords: Clostridium difficile; Colitis; Vancomycin; Megacolon
Citation: Salman MN (2020) Clinical Approach of Clostridium Difficile-Associated Diarrhea (CDAD) Treatment by Oral Vancomycin of Isolated Stool Samples of Contaminated Drinking Water in Basrah, Iraq. Clin Pharmacol Biopharm 9: 197. Doi: 10.4172/2167-065X.1000197
Copyright: © 2020 Salman MN. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share This Article
Open Access Journals
Article Tools
Article Usage
- Total views: 1442
- [From(publication date): 0-2020 - Apr 20, 2024]
- Breakdown by view type
- HTML page views: 886
- PDF downloads: 556
